Education and Awareness of Skin Cancer Risk in Liver Transplant and IBD Patients: A Comparison
Authors
Campbell V, McDougall N, Turner GBDepartments / Institutions
Royal Victoria Hospital, Belfast, UKPublication Date
Spring 2014Introduction
The risk of non-melanoma skin cancer (NMSC) is increased with immunosuppression therapy. Our aim was to compare how aware liver transplant and IBD patients, attending two separate services, were of this increased risk. Liver transplant recipients received formal education regarding skincare at time of transplantation. The IBD group received this on commencement of therapy and on an opportunistic basis. Thirty-four liver transplant patients (15 male, 19 female) and thirty-four IBD patients (19 male, 15 female) completed a questionnaire which assessed awareness of NMSC risk. Mean ages were 52 and 36 respectively. Of the transplant patients, 23 were on Tacrolimus, 2 on Azathioprine, 2 on Ciclosporin, and 7 on combination therapy. In the IBD group, 29 took Azathioprine and 5 Mercaptopurine.
Twenty-three (68%) transplant patients recalled being informed of the increased NMSC risk but two (6%) couldn’t remember and nine (26%) denied being informed. Eighteen (53%) IBD patients recalled being informed of the NMSC risk. Three (9%) couldn’t remember and thirteen (38%) denied being informed. For patients on therapy 10 years.
Latest News
Gastroenterology FK Meeting Provision and Challenges
Posted on: 2nd April 2021E-Publications
Download our latest Documents